In another study investigating the expression of VEGFR2 after treatment with hesperidin in a mouse model of glioma, it was shown that hesperidin (20 mg/kg) could significantly inhibit the HIF‐1a/VEGF/VEGFR2 pathway.20 The gene discussed is HIF1A; the disease is central nervous system cancer.